Ryan Arthur F 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2023/5/3 申報
- 申報編號
- 0001968202-23-000011
- 申報時間
- 2023/5/3
- 交易日
- 2023/5/1
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 7 筆非衍生性交易。公開市場賣出合計 $8.05 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Ryan Arthur FCIK 0001187443 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/5/1 | Common Stock | S賣出處分 | −16 | $802.67F2 | −$12,842.72 | 19,031 | 直接 | |
| 2023/5/1 | Common Stock | S賣出處分 | −30 | $803.58F3 | −$24,107.4 | 19,001 | 直接 | |
| 2023/5/1 | Common Stock | S賣出處分 | −2 | $804.51F4 | −$1,609.02 | 18,999 | 直接 | |
| 2023/5/1 | Common Stock | S賣出處分 | −5 | $805.34F5 | −$4,026.7 | 18,994 | 直接 | |
| 2023/5/1 | Common Stock | S賣出處分 | −15 | $806.53F6 | −$12,097.95 | 18,979 | 直接 | |
| 2023/5/1 | Common Stock | S賣出處分 | −17 | $807.50F7 | −$13,727.5 | 18,962 | 直接 | |
| 2023/5/1 | Common Stock | S賣出處分 | −15 | $808.11F8 | −$12,121.65 | 18,947 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents volume-weighted average price of sales of 16 shares of Company stock on May 1, 2023 at prices ranging from $802.57 to $802.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 30 shares of Company stock on May 1, 2023 at prices ranging from $803.22 to $803.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 2 shares of Company stock on May 1, 2023 at prices ranging from $804.20 to $804.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 5 shares of Company stock on May 1, 2023 at prices ranging from $805.22 to $805.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 15 shares of Company stock on May 1, 2023 at prices ranging from $806.01 to $806.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 17 shares of Company stock on May 1, 2023 at prices ranging from $807.12 to $807.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents volume-weighted average price of sales of 15 shares of Company stock on May 1, 2023 at prices ranging from $808.00 to $808.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。